ORIGINAL HOUSE                                           

BILL   NO.  0129

 

ENROLLED ACT NO. 55,  HOUSE OF REPRESENTATIVES

 

FIFTY-SIXTH LEGISLATURE OF THE STATE OF WYOMING

2001 GENERAL SESSION

 

 

 

 

AN ACT relating to the Wyoming Controlled Substances Act;
adding drugs to the schedule of drugs as specified;
repealing a drug from the schedule of drugs; and providing
for an effective date.

 

Be It Enacted by the Legislature of the State of Wyoming:

 

Section 1.  W.S. 35-7-1014(e) by creating a new
paragraph (iii), 35-7-1018(c) by creating new paragraphs
(xiii) and (xiv), (g) by creating new paragraphs (xxvi)
through (xxviii) and by creating a new subsection (h) and
35-7-1020(c) by creating a new paragraph (xlix), (e) by
creating new paragraphs (xi) and (xii) and (f) by creating
a new paragraph (ii) are amended to read:

 

35-7-1014.  Substances included in Schedule I.

 

(e)  Depressants. - Unless specifically excepted or
unless listed in another schedule, any material compound,
mixture or preparation which contains any quantity of the
following substances having a depressant effect on the
central nervous system, including its salts, isomers, and
salts of isomers whenever the existence of such salts,
isomers and salts of isomers is possible within the
specific chemical designation:

 

(iii)  Gamma-hydroxybutyric (some other names
include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-
hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate).

 

35-7-1018.  Substances included in Schedule III.

 

(c)  Depressants. - Unless specifically excepted or
listed in another schedule, any material, compound, mixture
or preparation which contains any quantity of the following

 

Page  1

 

 

 

substances having a depressant effect on the central
nervous system:

 

(xiii)  Ketamine, its salts, isomers and salts of
isomers (some other names for ketamine include (±)-2-(2-
chlorophenyl)-2-(methylamino)-cyclohexanone);

 

(xiv)  Any drug product containing gamma
hydoxybutyric acid, its salts, isomers and salts of
isomers, for which an application is approved under section
505 of the federal Food, Drug and Cosmetic Act.

 

(g)  Anabolic steroids. - Unless specifically excepted
or unless listed in another schedule, any of the following
or any isomer, ester, salt or derivative of the following
that acts in the same manner on the human body:

 

(xxvi)  Formebulone (formebolone);

 

(xxvii)  Methenolone;

 

(xxviii)  Any salt, ester or isomer of a drug or
substance described or listed in this paragraph, if that
salt, ester or isomer promotes muscle growth, except the
term does not include an anabolic steroid which is
expressly intended for administration through implants to
cattle or other nonhuman species and which has been
approved by the United States secretary of health and
humans services for such administration. If any person
prescribes, dispenses or distributes such steroid for human
use, the person shall be considered to have prescribed,
dispensed or distributed an anabolic steroid within the
meaning of this paragraph.

 

(h)  Hallucinogenic substances:

 

Page  2

 

 

 

(i)  Dronabinol (synthetic) in sesame oil and
encapsulated in a soft gelatin capsule in a United States
Food and Drug Administration approved drug product; some
other names for dronobinol include (6aR-trans)-6a,7,8,10a-
tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-
1-ol, or (-)-delta-9-(trans)-tetrahydrocannabinol.

 

35-7-1020.  Substances included in Schedule IV.

 

(c)  Depressants. - Unless specifically excepted or
unless listed in another schedule, any material, compound,
mixture or preparation which contains any quantity of the
following substances, including its salts, isomers and
salts of isomers whenever the existence of such salts,
isomers and salts of isomers is possible within the
specific chemical designation:

 

(xlix)  Zaleplon.

 

(e)  Stimulants. - Unless specifically excepted or
unless listed in another schedule, any material, compound,
mixture or preparation which contains any quantity of the
following substances having a stimulant effect on the
central nervous system, including its salts, isomers and
salts of isomers:

 

(xi)  Sibutramine;

 

(xii)  Modafinil.

 

(f)  Other substances. - Unless specifically excepted
or unless listed in another schedule, any material,
compound, mixture or preparation which contains any
quantity of the following substances, including its salts:

 

Page  3

 

 

 

(ii)  Butorphanol (including its optical
isomers).

 

Section 2.  W.S. 35-7-1016(g)(i) is repealed.

 

Section 3.  This act is effective July 1, 2001.

 

(END)

 

 

 

 

                                     

Speaker of the House                  President of the Senate

 

                                              

                 Governor                     

                                              

                 TIME APPROVED: _________     

                 DATE APPROVED: _________     

 

I hereby certify that this act originated in the House.

 

 

Chief Clerk

 

Page  4